diphenylcyclopropenone has been researched along with Disease Exacerbation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Garioch, J; Lo, MC; Moncrieff, MD | 1 |
| Baum, CL; Jakub, JW; Veverka, KK | 1 |
| Hoffmann, R; McElwee, KJ; Vitacolonna, M; Zöller, M | 1 |
3 other study(ies) available for diphenylcyclopropenone and Disease Exacerbation
| Article | Year |
|---|---|
Sequencing in management of in-transit melanoma metastasis: Diphencyprone versus isolate limb infusion.
Topics: Aged; Aged, 80 and over; Chemotherapy, Cancer, Regional Perfusion; Cost of Illness; Cyclopropanes; Disease Progression; Female; Humans; Male; Melanoma; Middle Aged; Retrospective Studies; Skin Neoplasms | 2020 |
Responses to Topical Diphenylcyclopropenone as an Adjunct Treatment for In-Transit Melanoma: A Tertiary Referral Center Experience.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Cyclopropanes; Disease Progression; Female; Haptens; Humans; Immunotherapy; Male; Melanoma; Middle Aged; Neoplastic Cells, Circulating; Retrospective Studies; Skin Neoplasms; Tertiary Care Centers; Treatment Outcome; Tumor Burden | 2018 |
The progressive state, in contrast to the stable or regressive state of alopecia areata, is reflected in peripheral blood mononuclear cells.
Topics: Adolescent; Adult; Aged; Alopecia Areata; B7-1 Antigen; CD40 Antigens; CD40 Ligand; Child; Cyclopropanes; Cytokines; Disease Progression; Female; Flow Cytometry; Humans; Inflammation; Leukocytes, Mononuclear; Ligands; Lymphocyte Activation; Male; Middle Aged; Receptors, IgG; Time Factors; Tumor Necrosis Factor-alpha | 2004 |